首站-论文投稿智能助手
典型文献
Norcantharidin ameliorates the development of murine lupus via inhibiting the generation of IL-17 producing cells
文献摘要:
Systemic lupus erythematosus(SLE)is a devastating autoimmune disorder associated with severe organ damage.The abnormality of T cell apoptosis is considered as an important pathogenetic mechanism of SLE.Norcantharidin(NCTD),a derivative of Cantharidin,is an efficacious anti-cancer drug by inhibiting cell proliferation and inducing cell apoptosis.Besides,NCTD has also been proved to protect the function of kidneys,while damaged renal function is the most important predictor of morbidity and mortality in SLE.All these suggest the potential effects of NCTD in SLE treatment.In this study we investigated whether NCTD exerted therapeutic effects in a mouse SLE model.Lupus prone female MRL/Ipr mice were treated with NCTD(1,2 mg·kg-1·d-1,ip)for 8 weeks.We showed that NCTD administration significantly decreased mortality rate,diminished the expression of anti-dsDNA IgG antibody,a diagnostic marker for SLE,as well as restored renal structure and function in MRL/Ipr mice.Moreover,NCTD administration dose-dependently inhibited lymphoproliferation and T cell accumulation in the spleens of MRL/Ipr mice.We further revealed that NCTD specifically inhibited DN T cell proliferation and Th17 cell differentiation both via blocking activation of signal transducer and activator of transcription 3(STAT3)signaling pathway.On the other hand,NCTD did not affect T cell apoptosis in MRL/Ipr mice.Taken together,our data suggest that NCTD may be as a promising therapeutic drug through targeting T cells for the treatment of SLE.
文献关键词:
作者姓名:
Li-jun Du;Yu-xiang Feng;Zhi-xing He;Lin Huang;Qiao Wang;Cheng-ping Wen;Yun Zhang
作者机构:
Institute of Basic Research in Clinical Medicine,College of Basic Medical Science,Zhejiang Chinese Medical University,Hangzhou 310053,China
引用格式:
[1]Li-jun Du;Yu-xiang Feng;Zhi-xing He;Lin Huang;Qiao Wang;Cheng-ping Wen;Yun Zhang-.Norcantharidin ameliorates the development of murine lupus via inhibiting the generation of IL-17 producing cells)[J].中国药理学报(英文版),2022(06):1521-1533
A类:
Norcantharidin,Cantharidin,Ipr,lymphoproliferation
B类:
ameliorates,development,murine,lupus,via,inhibiting,generation,producing,cells,Systemic,erythematosus,SLE,devastating,autoimmune,disorder,associated,severe,organ,abnormality,apoptosis,considered,important,pathogenetic,mechanism,NCTD,derivative,efficacious,cancer,drug,by,inducing,Besides,has,also,been,proved,protect,function,kidneys,while,damaged,renal,most,predictor,morbidity,mortality,All,these,suggest,potential,effects,treatment,In,this,study,investigated,whether,exerted,therapeutic,mouse,model,Lupus,prone,female,MRL,mice,were,treated,weeks,We,showed,that,administration,significantly,decreased,diminished,expression,dsDNA,IgG,antibody,diagnostic,marker,well,restored,structure,Moreover,dose,dependently,inhibited,accumulation,spleens,further,revealed,specifically,Th17,differentiation,both,blocking,activation,transducer,activator,transcription,STAT3,signaling,pathway,On,other,hand,did,not,affect,Taken,together,our,data,may,promising,through,targeting
AB值:
0.53456
相似文献
Romidepsin (FK228) improves the survival of allogeneic skin grafts through downregulating the production of donor-specific antibody via suppressing the IRE1 α-XBP1 pathway
Yuliang GUO;Siyu SONG;Xiaoxiao DU;Li TIAN;Man ZHANG;Hongmin ZHOU;Zhonghua Klaus CHEN;Sheng CHANG-Institute of Organ Transplantation,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Key Laboratory of Organ Transplantation,Ministry of Education,NHC Key Laboratory of Organ Transplantation,Key Laboratory of Organ Transplantation,Chinese Academy of Medical Sciences,Wuhan 430030,China;Henan Key Laboratory of Digestive Organ Transplantation,Open and Key Laboratory of Hepatobiliary&Pancreatic Surgery and Digestive Organ Transplantation at Henan Universities,Zhengzhou Key Laboratory of Hepatobiliary&Pancreatic Diseases and Organ Transplantation,Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;Department of Cardiothoracic and Vascular Surgery,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China
Globular adiponectin-mediated vascular remodeling by affecting the secretion of adventitial-derived tumor necrosis factor-αinduced by urotensin Ⅱ
Jun LI;Limin LUO;Yonggang ZHANG;Xiao DONG;Shuyi DANG;Xiaogang GUO;Wenhui DING-Department of Cardiology,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Division of Cardiology,Department of Internal Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,China;Division of Cardiology,Department of Internal Medicine,Peking University First Hospital,Beijing 100034,China;Department of Dermatology,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Department of Cardiovascular Diseases,the Second Affiliated Hospital,Shantou University Medical College,Shantou 515041,China
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
Leyi Yao;Qian Zhao;Ding Yan;Ziying Lei;Yali Hao;Jinghong Chen;Qian Xue;Xiaofen Li;Qingtian Huang;Daolin Tang;Q.Ping Dou;Xin Chen;Jinbao Liu-Affiliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,State Key Laboratory of Respiratory Disease,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;Institute of Digestive Disease of Guangzhou Medical University,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China;School of Public Health,Guangzhou Medical University,Guangzhou,511436,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
A novel PI3K inhibitor XH30 suppresses orthotopic glioblastoma and brain metastasis in mice models
Ming Ji;Dongjie Wang;Songwen Lin;Chunyang Wang;Ling Li;Zhihui Zhang;Jing Jin;Deyu Wu;Yi Dong;Heng Xu;Duo Lu;Xiaoguang Chen-State Key Laboratory of Bioactive Substances and Functions of Natural Medicines,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。